Invited commentary.
Mentzer
Robert M
RM
Department of Surgery, University of Kentucky College of Medicine, MN264, Lexington, KY 40536-0298, USA. mentzer@email.uky.edu
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D003131:Combined Modality Therapy / Q000379:methods; D003981:Diazoxide / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D006146:Guanidines / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000150:complications / Q000628:therapy; D015428:Myocardial Reperfusion Injury / Q000188:drug therapy* / Q000209:etiology*; D013450:Sulfones / Q000627:therapeutic use*; D013552:Swine; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D006146:Guanidines; D013450:Sulfones; D014665:Vasodilator Agents; C093373:cariporide; D003981:Diazoxide